Authors:
GOURLAY GK
CHERRY DA
ONLEY MM
TORDOFF SG
CONN DA
HOOD GM
PLUMMER JL
Citation: Gk. Gourlay et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF 24-HOURLY KAPANOL COMPARED TO 12-HOURLY MS CONTIN IN THE TREATMENT OF SEVERE CANCER PAIN, Pain, 69(3), 1997, pp. 295-302
Authors:
CHERRY DA
GOURLAY GK
ONLEY MM
TORDOFF SG
CONN DA
MALDEN T
Citation: Da. Cherry et al., ONCE-A-DAY (IE 24 HOURLY) KAPANOL(TM), A NEW SUSTAINED-RELEASE MORPHINE FORMULATION, IN THE TREATMENT OF CANCER PAIN - MORPHINE METABOLITE PROFILES, European journal of cancer, 31A, 1995, pp. 884-884
Authors:
GOURLAY GK
CHERRY DA
ONLEY MM
TORDOFF SG
CONN DA
PLUMMER JL
Citation: Gk. Gourlay et al., ONCE-A-DAY (IE 24 HOURLY) KAPANOL(TM), A NEW SUSTAINED-RELEASE MORPHINE FORMULATION, IN THE TREATMENT OF CANCER PAIN - PHARMACOKINETIC ASPECTS, European journal of cancer, 31A, 1995, pp. 897-897
Citation: Gk. Gourlay et al., CHRONOPHARMACOKINETIC VARIABILITY IN PLASMA MORPHINE CONCENTRATIONS FOLLOWING ORAL DOSES OF MORPHINE SOLUTION, Pain, 61(3), 1995, pp. 375-381
Authors:
PLUMMER JL
CMIELEWSKI PL
TALLENTS S
HALL PD
ODONTIADIS J
GOURLAY GK
OWEN H
Citation: Jl. Plummer et al., DEVELOPMENT OF TOLERANCE TO ANTINOCICEPTIVE EFFECTS OF AN INTRATHECALMORPHINE CLONIDINE COMBINATION IN RATS/, Naunyn-Schmiedeberg's archives of pharmacology, 351(6), 1995, pp. 618-623
Citation: Da. Cherry et Gk. Gourlay, PHARMACOLOGICAL MANAGEMENT OF CHRONIC PAIN - A CLINICIAN PERSPECTIVE, Agents and actions, 42(3-4), 1994, pp. 173-174